(Q38760080)

6 September 2017

1 reference

title

Clinical features and treatment of Lyme disease (English)

1 reference

6 September 2017

0 references

Tortorice KL

1

1 reference

PubMed ID

2694112

6 September 2017

Heim-Duthoy KL

series ordinal

2

1 reference

PubMed ID

2694112

6 September 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

6 September 2017

1 reference

6 September 2017

9

1 reference

6 September 2017

6

1 reference

6 September 2017

363-371

1 reference

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities

6 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Cases of Lyme Disease in the United States: Locations Correlated with Distribution of Ixodes dammini

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Borrelia burgdorferi sp. nov.: Etiologic Agent of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Lyme carditis: cardiac abnormalities of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

21 January 2018

Chronic Lyme Arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

The early clinical manifestations of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Unilateral blindness caused by infection with the Lyme disease spirochete, Borrelia burgdorferi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Chronic neurologic manifestations of erythema migrans borreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Nervous system abnormalities in Lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Treatment of Lyme borreliosis with emphasis on neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Elevated levels of collagenase and prostaglandin E2 from synovium associated with erosion of cartilage and bone in a patient with chronic Lyme arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Diagnosing early Lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Laboratory aspects of Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Antibody Response in Lyme Disease: Evaluation of Diagnostic Tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Cross-reactivity in serological tests for Lyme disease and other spirochetal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Serologic diagnosis of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Lyme disease, 1988: immunologic manifestations and possible immunopathogenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Antibiotic therapy in Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Treatment of the Early Manifestations of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Penicillin-resistant Borrelia encephalitis responding to cefotaxime.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Cefotaxime diffusion into cerebrospinal fluid of children with meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

New Chemotherapeutic Approaches in the Treatment of Lyme Borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Successful parenteral penicillin therapy of established Lyme arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

The Spirochetal Etiology of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

Spirochetes Isolated from the Blood of Two Patients with Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1989.TB04150.X

10.1002/J.1875-9114.1989.TB04150.X

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference

PubMed ID

2694112